Affiliation:
1. Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-210 Gdansk, Poland
2. First Department of Cardiology, Medical University of Gdansk, 80-210 Gdansk, Poland
Abstract
Psoriasis comorbidities may emerge from pleiotropic mechanisms, including common proinflammatory pathways, cellular mediators or genetic predisposition. Obesity is considered to be an independent risk factor of psoriasis, which may influence the severity of the disease and its early onset, decrease patients’ quality of life, alter response to psoriasis therapies and affect morbidity by reduced life expectancy due to cardiovascular events. Although novel approaches, including genetic techniques, have provided a wide range of new research, there are still scarce studies elaborating on the common genetic background of psoriasis and obesity. The aim of this study was to present and evaluate a possible common genetic background of psoriasis and concomitant increased body mass based on the review of the available literature.
Subject
Genetics (clinical),Genetics
Reference79 articles.
1. Pathogenesis of psoriasis in the “omic” era. Part II. Genetic, genomic and epigenetic changes in psoriasis;Nedoszytko;Postep. Dermatol. Alergol.,2020
2. The current landscape of psoriasis genetics in 2020;Ogawa;J. Dermatol. Sci.,2020
3. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene;Nair;Am. J. Hum. Genet.,2006
4. Chiricozzi, A., Romanelli, P., Volpe, E., Borsellino, G., and Romanelli, M. (2018). Scanning the Immunopathogenesis of Psoriasis. Int. J. Mol. Sci., 19.
5. Vičić, M., Kaštelan, M., Brajac, I., Sotošek, V., and Massari, L.P. (2021). Current Concepts of Psoriasis Immunopathogenesis. Int. J. Mol. Sci., 22.